Skip to content

OptimizeRx Corporation: 10-Q filed 2022-08-09

What OptimizeRx Corporation reported in its quarterly report filed 2022-08-09 (fiscal Q2 2022): 38 published measures, 108 facts as tagged in accession 0001213900-22-045964.

This filing

Form
10-Q (quarterly report)
Filed
2022-08-09
Fiscal period
fiscal Q2 2022
Accession
0001213900-22-045964 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All OptimizeRx Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-06-30147,448,264USD
At 2021-12-31140,985,192USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-06-306,631,062USD
At 2021-12-319,605,475USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-06-30140,817,202USD
At 2022-03-31131,050,845USD
At 2021-12-31131,379,717USD
At 2021-06-30124,675,142USD
At 2021-03-31121,835,237USD
At 2020-12-3149,973,914USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-06-3087,392,970USD
At 2021-12-3184,681,770USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-3,884,714USD91
2022-01-01 to 2022-06-30-7,645,812USD181
2022-01-01 to 2022-03-31-3,761,098USD90
2021-04-01 to 2021-06-30352,100USD91
2021-01-01 to 2021-06-30-285,277USD181
2021-01-01 to 2021-03-31-637,377USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-06-304,388,372USD181
2021-01-01 to 2021-06-301,855,654USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-06-3041,335USD181
2021-01-01 to 2021-06-3043,654USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-04-01 to 2022-06-3013,978,665USD91
2022-01-01 to 2022-06-3027,710,195USD181
2021-04-01 to 2021-06-3013,625,639USD91
2021-01-01 to 2021-06-3024,854,850USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-06-30509,420USD181
2021-01-01 to 2021-06-3071,771,501USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-2,186,592USD181
2021-01-01 to 2021-06-30-220,476USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-06-30-42,899,470USD
At 2021-12-31-35,253,658USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-04-01 to 2022-06-3018,122,500shares91
2022-01-01 to 2022-06-3018,000,958shares181
2021-04-01 to 2021-06-3017,347,096shares91
2021-01-01 to 2021-06-3016,720,114shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-04-01 to 2022-06-3018,122,500shares91
2022-01-01 to 2022-06-3018,000,958shares181
2021-04-01 to 2021-06-3018,104,807shares91
2021-01-01 to 2021-06-3016,720,114shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.21USD/shares91
2022-01-01 to 2022-06-30-0.42USD/shares181
2021-04-01 to 2021-06-300.02USD/shares91
2021-01-01 to 2021-06-30-0.02USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.21USD/shares91
2022-01-01 to 2022-06-30-0.42USD/shares181
2021-04-01 to 2021-06-300.02USD/shares91
2021-01-01 to 2021-06-30-0.02USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-06-30143,337USD
At 2021-12-31143,818USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-06-307,199,421USD181
2021-01-01 to 2021-06-301,354,106USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-3,908,530USD91
2022-01-01 to 2022-06-30-7,669,632USD181
2021-04-01 to 2021-06-30340,139USD91
2021-01-01 to 2021-06-30-298,169USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-06-30110,406,662USD
At 2021-12-31115,113,010USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-06-306,441,260USD
At 2021-12-319,368,749USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2022-06-3022,673,820USD
At 2021-12-3114,740,031USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-06-3018,732,849USD
At 2021-12-3124,800,585USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2022-01-01 to 2022-06-30321,054USD181

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-04-01 to 2022-06-3012,898,479USD91
2022-01-01 to 2022-06-3024,761,253USD181
2021-04-01 to 2021-06-307,704,536USD91
2021-01-01 to 2021-06-3014,467,452USD181

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-04-01 to 2022-06-308,989,949USD91
2022-01-01 to 2022-06-3017,091,621USD181
2021-04-01 to 2021-06-308,044,675USD91
2021-01-01 to 2021-06-3014,169,283USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2022-04-01 to 2022-06-304,988,716USD91
2022-01-01 to 2022-06-3010,618,574USD181
2021-04-01 to 2021-06-305,580,964USD91
2021-01-01 to 2021-06-3010,685,567USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2022-04-01 to 2022-06-303,891,607USD91
2022-01-01 to 2022-06-307,274,416USD181
2021-04-01 to 2021-06-302,900,702USD91
2021-01-01 to 2021-06-305,375,649USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-06-3018,174,182shares
At 2021-12-3117,860,975shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-06-3087,392,970USD
At 2021-12-3184,681,770USD
At 2021-06-3083,923,455USD
At 2020-12-3110,516,776USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-06-30183,698,497USD
At 2021-12-31166,615,514USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-06-30278,513USD
At 2021-12-31328,820USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-06-301,638,791USD
At 2021-12-312,902,836USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-3,884,714USD91
2022-01-01 to 2022-06-30-7,645,812USD181
2021-04-01 to 2021-06-30352,100USD91
2021-01-01 to 2021-06-30-285,277USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-01-01 to 2022-06-301,049,656USD181
2021-01-01 to 2021-06-301,054,138USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2022-04-01 to 2022-06-3023,816USD91
2022-01-01 to 2022-06-3023,820USD181
2021-04-01 to 2021-06-3011,961USD91
2021-01-01 to 2021-06-3012,892USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-01-01 to 2021-06-3070,671,536USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-5,969,009USD181
2021-01-01 to 2021-06-3088,221USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-3064,232USD181
2021-01-01 to 2021-06-30187,211USD181

Inspect the source

Entity
OptimizeRx Corporation / CIK 0001448431
Captured
2026-09-20T09:05:08.152Z
SEC response SHA-256
e280d2de9ab6667276acbbb5def7abe84fc4602cbf3198471c8ba2bbfd13a64f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001448431.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))